2m 2m 2m 2m 2m 2m 2m
Ardelyx (ARDX)
NASDAQ
$6.23-$0.15 (-2.28%)
Price as of Jun 23, 2026 7:57 PM EDT- $1.6BMarket Cap
- 75.48%1-Year Change
- BiotechnologyIndustry
Ardelyx (ARDX)
$6.23-$0.15 (-2.28%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 35.0M -89.51% | 333.6M +168.06% | 124.5M +138.61% | 52.2M +416.57% | |
Cost of Revenue | 39.5M -21.80% | 50.6M +184.10% | 17.8M +332.23% | 4.1M +311.70% | |
Gross Profit | -4.5M -101.60% | 283.1M +165.38% | 106.7M +122.02% | 48.0M +428.10% | |
Sales and Marketing Expense | 337.2M +30.36% | 258.7M +92.48% | 134.4M N/A | N/A N/A | |
Research and Development Expense | -71.5M +36.72% | -52.3M +47.22% | -35.5M +0.95% | -35.2M -61.38% | |
Depreciation and Amortization Expense | 3.1M +48.28% | 2.1M +59.67% | 1.3M +12.94% | 1.1M -20.61% | |
Total Operating Expenses | 448.3M +44.14% | 311.0M +83.01% | 169.9M +46.60% | 115.9M -29.51% | |
Operating Profit | -41.0M +46.61% | -27.9M -55.83% | -63.3M -0.76% | -63.8M -58.69% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -5.0M +45.59% | -3.4M -24.48% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -5.0M +45.59% | -3.4M -24.48% | |
Total Nonoperating Income and Expense | 8.7M -4.68% | 9.2M +38.37% | 6.6M +306.00% | 1.6M +137.70% | |
Income before Taxes | -60.6M +55.98% | -38.9M -40.67% | -65.5M -2.50% | -67.2M -57.51% | |
Income Taxes | 969,000 +264.29% | 266,000 -51.37% | 547,000 +6,737.50% | 8,000 +100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | -102,000 N/A | |
Net Income | -61.6M +57.40% | -39.1M -40.76% | -66.1M -1.70% | -67.2M -57.51% | |
Net Income from Continuing Operations Applicable to Common | -60.6M +55.98% | -38.9M -40.67% | -65.5M -2.50% | -67.2M -57.51% | |
Basic EPS and Net Income | -0.26 +52.94% | -0.17 -43.33% | -0.30 -28.57% | -0.42 -72.37% | |
Diluted EPS and Net Income | -0.26 +52.94% | -0.17 -43.33% | -0.30 -28.57% | -0.42 -72.37% | |
Basic Weighted Average Shares | 241.0M +2.47% | 235.2M +7.25% | 219.3M +38.21% | 158.7M +52.29% | |
Diluted Weighted Average Shares | 241.0M +2.47% | 235.2M +7.25% | 219.3M +38.21% | 158.7M +52.29% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 68.0M +4.72% | 64.9M +202.43% | 21.5M -77.67% | 96.1M +32.74% | |
Short-Term Investments | 196.7M +6.22% | 185.2M +13.72% | 162.8M +486.37% | 27.8M -37.26% | |
Cash and Cash Equivalents and Short-Term Investments | 264.7M +5.83% | 250.1M +35.70% | 184.3M +48.74% | 123.9M +6.19% | |
Total Current Assets | 382.3M +7.26% | 356.5M +44.83% | 246.1M +60.23% | 153.6M +14.93% | |
Accumulated Depreciation | 2.6M -75.04% | 10.6M +4.09% | 10.2M +5.63% | 9.7M -39.23% | |
Property and Plant and Equipment and Net | 2.2M +46.09% | 1.5M +48.17% | 1.0M -17.50% | 1.2M -48.22% | |
Total Long-Term Assets | 6.9M +28.06% | 5.4M +50.61% | 3.6M +308.17% | 881,000 -23.39% | |
Total Assets | 501.6M +15.11% | 435.8M +46.43% | 297.6M +56.57% | 190.1M +26.78% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 -100.00% | 26.7M -17.21% | |
Total Current Liabilities | 88.6M +13.84% | 77.8M +54.45% | 50.4M -23.18% | 65.6M +24.20% | |
Total Long-Term Debt | 202.8M +34.46% | 150.9M +202.78% | 49.8M +86.52% | 26.7M N/A | |
Total Long-Term Liabilities | 17.3M +110.05% | 8.3M -20.39% | 10.4M -30.32% | 14.9M +2.80% | |
Total Liabilities | 334.7M +27.50% | 262.5M +100.72% | 130.8M +42.54% | 91.7M +36.32% | |
Retained Earnings | -946.9M +6.96% | -885.3M +4.62% | -846.2M +8.47% | -780.1M +9.43% | |
Total Stockholders Equity | 166.9M -3.66% | 173.3M +3.88% | 166.8M +69.65% | 98.3M +19.02% | |
Total Shares Outstanding | 244.4M +2.66% | 238.0M +2.39% | 232.5M +17.06% | 198.6M +52.54% | |
Cash Flow | |||||
Cash from Operating Activities | -42.5M -5.19% | -44.8M -50.06% | -89.7M +28.09% | -70.0M -54.08% | |
Capital Expenditures | 1.5M +47.58% | 1.0M +193.90% | 344,000 +525.45% | 55,000 -97.05% | |
Cash from Investing Activities | -9.0M -51.09% | -18.3M -86.04% | -131.2M -812.72% | 18.4M -63.86% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 54.5M -48.86% | 106.6M -27.14% | 146.3M +94.18% | 75.3M -9.23% | |
Financials Ratio | |||||
Gross Margin | -12.96% -115.28% | 84.85% -1.00% | 85.70% -6.95% | 92.11% +2.23% | |
Operating Margin | -117.08% +1,297.45% | -8.38% -83.52% | -50.84% -58.41% | -122.24% -92.00% | |
Return on Assets | -13.14% +23.14% | -10.67% -60.61% | -27.10% -31.46% | -39.54% -56.07% | |
Return on Equity | -36.21% +57.34% | -23.01% -53.82% | -49.83% -32.91% | -74.28% -50.98% | |
Revenue Growth | -89.51% -153.26% | 168.06% +21.24% | 138.61% -66.73% | 416.57% +1,148.55% | |
Current Ratio | 4.31 -5.79% | 4.58 -6.22% | 4.88 +108.58% | 2.34 -7.46% | |
Cash Ratio | 0.77 -8.02% | 0.83 +95.80% | 0.43 -70.92% | 1.47 +6.88% | |
Debt-to-Equity Ratio | 1.21 +39.56% | 0.87 +191.43% | 0.30 -45.02% | 0.54 +39.13% | |
Debt-to-Assets Ratio | 0.40 +16.81% | 0.35 +106.81% | 0.17 -40.45% | 0.28 +30.62% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow